Guy Boeckxstaens
Clinical trials sponsored by Guy Boeckxstaens, explained in plain language.
-
New hope for IBS sufferers: allergy drug may beat standard treatment
Symptom relief Recruiting nowThis study tests whether ebastine, an allergy medication, works better than mebeverine, a common IBS drug, for reducing belly pain and improving daily life. About 200 adults with non-constipated IBS will take one of the two pills for 12 weeks. The goal is to see if ebastine provi…
Phase 3 • Sponsor: Guy Boeckxstaens • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could a new drug calm the gut and stop IBS pain?
Knowledge-focused Recruiting nowThis study looks at whether a new drug called UCB8600 can stop mast cells in the gut from overreacting, which may cause pain in people with irritable bowel syndrome (IBS). Researchers will take gut tissue from 60 people (some with IBS, some healthy) and treat it with UCB8600 in t…
Sponsor: Guy Boeckxstaens • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC